| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 2-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
BMRN
BioMarin Pharmaceutical
|
Aug 07, 2026 | BUY |
Strong Buy
+40.8% avg upside
52 analysts
|
$80.00
16.59% Upside
|
+9.1% | · |
|
HALO
Halozyme
|
Aug 07, 2026 | HOLD |
Strong Buy
-36.5% avg upside
20 analysts
|
$95.00
7.35% Downside
|
+0.9% | · |
|
TVTX
Travere Therapeutics
|
Aug 06, 2026 | BUY |
Strong Buy
-8.0% avg upside
22 analysts
|
$80.00
30.89% Upside
|
-1.3% | · |
|
LLY
Eli Lilly & Co
|
Aug 05, 2026 | BUY |
Strong Buy
-14.0% avg upside
48 analysts
|
$1330.00
8.82% Upside
|
+4.5% | · |
|
PFE
Pfizer
|
Aug 05, 2026 | HOLD |
Buy
+24.0% avg upside
45 analysts
|
$28.00
3.79% Upside
|
+4.8% | · |
|
MRK
Merck & Company
|
Aug 05, 2026 | BUY |
Strong Buy
-0.9% avg upside
43 analysts
|
$150.00
14.95% Upside
|
+0.2% | · |
|
GILD
Gilead Sciences
|
Aug 05, 2026 | BUY |
Strong Buy
-10.7% avg upside
66 analysts
|
$165.00
24.19% Upside
|
+1.0% | · |
|
VRTX
Vertex Pharmaceuticals
|
Aug 04, 2026 | BUY |
Strong Buy
-14.3% avg upside
62 analysts
|
$550.00
4.49% Upside
|
+3.6% | · |
|
VERA
Vera Therapeutics
|
Aug 04, 2026 | BUY |
Strong Buy
+122.0% avg upside
19 analysts
|
$70.00
121.74% Upside
|
+9.8% | · |
|
AMGN
Amgen
|
Aug 04, 2026 | HOLD |
Buy
-23.9% avg upside
57 analysts
|
$400.00
3.34% Downside
|
+7.0% | · |
|
ABBV
AbbVie
|
Aug 03, 2026 | BUY |
Strong Buy
-3.4% avg upside
46 analysts
|
$295.00
20.14% Upside
|
+2.0% | · |
|
JAZZ
Jazz Pharmaceuticals
|
Aug 03, 2026 | BUY |
Strong Buy
-7.9% avg upside
35 analysts
|
$300.00
16.59% Upside
|
-1.5% | · |
|
NBIX
Neurocrine
|
Jul 31, 2026 | BUY |
Strong Buy
+14.1% avg upside
37 analysts
|
$200.00
21.48% Upside
|
-2.0% | · |
|
REGN
Regeneron
|
Jul 31, 2026 | HOLD |
Strong Buy
-2.3% avg upside
58 analysts
|
$750.00
6.75% Downside
|
+2.9% | · |
|
BMY
Bristol-Myers Squibb
|
Jul 31, 2026 | HOLD |
Buy
-5.9% avg upside
42 analysts
|
$65.00
0.00% Downside
|
-0.7% | · |
|
BIIB
Biogen
|
Jul 30, 2026 | BUY |
Strong Buy
+21.9% avg upside
52 analysts
|
$250.00
20.73% Upside
|
+0.0% | · |
|
SMMT
Summit Therapeutics
|
Jul 27, 2026 | BUY |
Strong Buy
+96.0% avg upside
27 analysts
|
$30.00
105.68% Upside
|
+13.5% | · |
|
BNTX
BioNTech SE
|
Jul 24, 2026 | BUY |
Strong Buy
+43.6% avg upside
26 analysts
|
$140.00
50.66% Upside
|
+3.5% | · |
|
MIST
Milestone Pharmaceuticals
|
Jul 22, 2026 | BUY |
Strong Buy
+552.0% avg upside
7 analysts
|
$7.00
457.82% Upside
|
+0.8% | · |
|
IRWD
Ironwood Pharma
|
May 05, 2026 | HOLD |
Buy
+189.3% avg upside
23 analysts
|
$5.00
22.65% Upside
|
-7.5% | · |
|
WVE
Wave Life Sciences
|
Apr 01, 2026 | BUY |
Strong Buy
+246.2% avg upside
28 analysts
|
$13.00
115.71% Upside
|
-10.7% | · |
|
MLYS
Mineralys Therapeutics, Inc.
|
Mar 13, 2026 | BUY |
Strong Buy
+64.8% avg upside
12 analysts
|
$55.00
102.80% Upside
|
+3.6% | · |
|
XENE
Xenon
|
Aug 12, 2025 | BUY |
Strong Buy
-2.7% avg upside
28 analysts
|
$47.00
25.86% Downside
|
+78.0% | · |
|
ARWR
Arrowhead Pharmaceuticals
|
Jul 02, 2021 | BUY |
Strong Buy
-14.8% avg upside
27 analysts
|
$95.00
7.88% Upside
|
-43.5% | · |
|
FTH
Faeth Therapeutics
|
Jun 29, 2021 | BUY |
Strong Buy
+63.1% avg upside
16 analysts
|
$14.00
51.58% Downside
|
-85.3% | · |
|
NMTRQ
9 Meters Biopharma
|
Jun 04, 2021 | BUY |
Buy
+3234374900.0% avg upside
11 analysts
|
$3.00
299999899.95% Upside
|
· | · |
|
PLRX
Pliant Therapeutics
|
Apr 05, 2021 | BUY |
Buy
+2032.1% avg upside
21 analysts
|
$52.00
4852.46% Upside
|
· | · |
|
FBRX
Forte Biosciences
|
Mar 26, 2021 | BUY |
Buy
-35.4% avg upside
15 analysts
|
$75.00
2.33% Downside
|
· | · |
|
IDYA
IDEAYA Biosciences
|
Mar 24, 2021 | BUY |
Strong Buy
+32.1% avg upside
29 analysts
|
$33.00
9.84% Downside
|
-35.0% | · |
|
CHRS
Coherus Biosciences
|
Feb 25, 2021 | BUY |
Buy
+878.4% avg upside
18 analysts
|
$27.00
2001.27% Upside
|
-54.5% | · |
|
STTK
Shattuck Labs
|
Jan 20, 2021 | BUY |
Strong Buy
+204.8% avg upside
15 analysts
|
$75.00
943.03% Upside
|
-94.2% | · |
|
AGIO
Agios Pharma
|
Dec 23, 2020 | BUY |
Strong Buy
+87.6% avg upside
29 analysts
|
$65.00
100.36% Upside
|
-38.3% | · |
|
CTMX
CytomX Therapeutics
|
Sep 15, 2020 | HOLD |
Strong Buy
+217.3% avg upside
21 analysts
|
$8.50
150.44% Upside
|
-77.0% | · |
|
ADAPY
Adaptimmune Therapeutics
|
Apr 27, 2020 | BUY |
Buy
+7723.8% avg upside
10 analysts
|
$5.00
16566.74% Upside
|
· | · |
|
AVTR
Avantor
|
Jun 11, 2019 | BUY |
Buy
+13.0% avg upside
26 analysts
|
$21.00
53.44% Upside
|
+89.9% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.